These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21286880)

  • 1. Assessment of the influence factors on nasal spray droplet velocity using phase-Doppler anemometry (PDA).
    Liu X; Doub WH; Guo C
    AAPS PharmSciTech; 2011 Mar; 12(1):337-43. PubMed ID: 21286880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the influence factors on in vitro testing of nasal sprays using Box-Behnken experimental design.
    Guo C; Stine KJ; Kauffman JF; Doub WH
    Eur J Pharm Sci; 2008 Dec; 35(5):417-26. PubMed ID: 18832029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of droplet velocity and size from nasal spray devices using phase Doppler anemometry (PDA).
    Liu X; Doub WH; Guo C
    Int J Pharm; 2010 Mar; 388(1-2):82-7. PubMed ID: 20043981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidation of Formulation and Delivery Device-Related Effects on In Vitro Performance of Nasal Spray with Implication to Rational Product Specification Identification.
    Grmaš J; Stare K; Božič D; Injac R; Dreu R
    J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):230-246. PubMed ID: 28075184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of different parameters that affect droplet-size distribution from nasal sprays using the Malvern Spraytec.
    Dayal P; Shaik MS; Singh M
    J Pharm Sci; 2004 Jul; 93(7):1725-42. PubMed ID: 15176062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated actuation of nasal spray products: effect of hand-related variability on the in vitro performance of Flonase nasal spray.
    Doughty DV; Hsu W; Dalby RN
    Drug Dev Ind Pharm; 2014 Jun; 40(6):711-8. PubMed ID: 23594299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of metered dose inhaler spray velocities using phase Doppler anemometry (PDA).
    Liu X; Doub WH; Guo C
    Int J Pharm; 2012 Feb; 423(2):235-9. PubMed ID: 22183132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing quantitative relationships between changes in nasal spray in vitro metrics and drug delivery to the posterior nasal region.
    Kolanjiyil AV; Walenga R; Babiskin A; Golshahi L; Hindle M; Longest W
    Int J Pharm; 2023 Mar; 635():122718. PubMed ID: 36781083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propagation of uncertainty in nasal spray in vitro performance models using Monte Carlo simulation: part I. Model prediction using Monte Carlo simulation.
    Guo C; Doub WH; Kauffman JF
    J Pharm Sci; 2010 Apr; 99(4):2114-22. PubMed ID: 19902528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Box-Behnken experimental design in the development of a nasal drug delivery system of model drug hydroxyurea: characterization of viscosity, in vitro drug release, droplet size, and dynamic surface tension.
    Dayal P; Pillay V; Babu RJ; Singh M
    AAPS PharmSciTech; 2005 Nov; 6(4):E573-85. PubMed ID: 16408859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurements of droplet size distribution and analysis of nasal spray atomization from different actuation pressure.
    Inthavong K; Fung MC; Yang W; Tu J
    J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):59-67. PubMed ID: 24914675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of actuation parameters on in vitro testing of nasal spray products.
    Guo C; Doub WH
    J Pharm Sci; 2006 Sep; 95(9):2029-40. PubMed ID: 16865693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of formulation- and administration-related variables on deposition pattern of nasal spray pumps evaluated using a nasal cast.
    Kundoor V; Dalby RN
    Pharm Res; 2011 Aug; 28(8):1895-904. PubMed ID: 21499839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Comparison of Local Nasal Vaccine Delivery and Correlation with Device Spray Performance.
    Li L; Wilkins JV; Esmaeili AR; Rahman N; Golshahi L
    Pharm Res; 2023 Feb; 40(2):537-550. PubMed ID: 36536098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High resolution visualization and analysis of nasal spray drug delivery.
    Inthavong K; Fung MC; Tong X; Yang W; Tu J
    Pharm Res; 2014 Aug; 31(8):1930-7. PubMed ID: 24549819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of impaction force of nasal sprays and metered-dose inhalers using the Texture Analyser.
    Guo C; Ye W; Kauffman J; Doub WH
    J Pharm Sci; 2009 Aug; 98(8):2799-806. PubMed ID: 19097159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary break-up and atomization characteristics of a nasal spray.
    Shrestha K; Van Strien J; Singh N; Inthavong K
    PLoS One; 2020; 15(8):e0236063. PubMed ID: 32756567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel nano-cellulose excipient for generating non-Newtonian droplets for targeted nasal drug delivery.
    Young PM; Traini D; Ong HX; Granieri A; Zhu B; Scalia S; Song J; Spicer PT
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1729-1733. PubMed ID: 28581833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a laboratory and a production coating spray gun with respect to scale-up.
    Mueller R; Kleinebudde P
    AAPS PharmSciTech; 2007 Jan; 8(1):3. PubMed ID: 17408226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of spray properties on intranasal deposition.
    Foo MY; Cheng YS; Su WC; Donovan MD
    J Aerosol Med; 2007; 20(4):495-508. PubMed ID: 18158721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.